Erratum to: Evidence of a stabilizing mutation of β-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas

Starker, Lee; Fonseca, Annabelle; Åkerström, Göran; Björklund, Peyman; Westin, Gunnar; Carling, Tobias
December 2012
Endocrine (1355008X);Dec2012, Vol. 42 Issue 3, p769
Academic Journal
Correction notice
A correction to the article "Evidence of a Stabilizing Mutation of β-Catenin Encoded by Ctnnb1 Exon 3 in a Large Series of Sporadic Parathyroid Adenomas" that was published online on July 28, 2012 is presented.


Related Articles

  • HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. Howell, V.M.; Haven, C.J.; Kahnoski, K.; Khoo, S.K.; Petillo, D.; Chen, J.; Fleuren, G.J.; Robinson, B.G.; Delbridge, L.W.; Philips, J.; Nelson, A.E.; Krause, U.; Hammje, K.; Dralle, H.; Hoang-Vu, C.; Gimm, O.; Marsh, D.J.; Morreau, H.; Teh, B.T. // Journal of Medical Genetics;Sep2003, Vol. 40 Issue 9, p657 

    Background: Hyperparathyroidism is a common endocrinopathy characterised by the formation of parathyroid tumours. In this study, we determine the role of the recently identified gene, HRPT2, in parathyroid tumorigenesis. Methods: Mutation analysis of HRPT2 was undertaken in 60 parathyroid...

  • Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients. Björklund, Peyman; Lindberg, Daniel; Åkerström, Göran; Westin, Gunnar // Molecular Cancer;2008, Vol. 7, Special section p1 

    Background: Aberrant accumulation of β-catenin plays an important role in a variety of human neoplasms. We recently reported accumulation of β-catenin in parathyroid adenomas from patients with primary hyperparathyroidism (pHPT). In CTNNB1 exon 3, we detected a stabilizing mutation (S37A)...

  • CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort. Guarnieri, Vito; Battista, Claudia; Muscarella, Lucia; Bisceglia, Michele; Martino, Danilo; Baorda, Filomena; Maiello, Evaristo; D'Agruma, Leonardo; Chiodini, Iacopo; Clemente, Celeste; Minisola, Salvatore; Romagnoli, Elisabetta; Corbetta, Sabrina; Viti, Raffaella; Eller-Vainicher, Cristina; Spada, Anna; Iacobellis, Michela; Malavolta, Nazzarena; Carella, Massimo; Canaff, Lucie // Cellular Oncology (2211-3428);Dec2012, Vol. 35 Issue 6, p411 

    Objective: To determine if molecular and immunohistochemical (IHC) features of the HRPT2/CDC73 gene and its product, parafibromin, predict the natural history of parathyroid malignancy, particularly atypical adenoma, as seen in a single-centre patient cohort. Methods: Matched tumor and non-tumor...

  • Expression and somatic mutations of SDHAF2 (SDH5), a novel endocrine tumor suppressor gene in parathyroid tumors of primary hyperparathyroidism. Starker, Lee; Delgado-Verdugo, Alberto; Udelsman, Robert; Björklund, Peyman; Carling, Tobias // Endocrine (1355008X);Dec2010, Vol. 38 Issue 3, p397 

    To investigate the SDHAF2 gene and its effect on primary hyperparathyroidism. Parathyroid tumors causing primary hyperparathyroidism (pHPT) are one of the more common endocrine neoplasias. Loss of heterozygosity at chromosome 11q13 is the most common chromosomal aberration in parathyroid tumors...

  • Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours. Juhlin, C.; Haglund, Felix; Obara, Takao; Arnold, Andrew; Larsson, Catharina; Höög, Anders; Juhlin, C Christofer; Höög, Anders // Virchows Archiv;Jul2011, Vol. 459 Issue 1, p47 

    Hyperparathyroidism 2 (HRPT2) gene mutations underlie hereditary and sporadic forms of primary hyperparathyroidism (PHPT), and the encoded product parafibromin has been established as a marker for facilitating parathyroid tumour classification. HRPT2 mutations and reduced nuclear expression of...

  • Expression of Parafibromin in Distant Metastatic Parathyroid Tumors in Patients with Advanced Secondary Hyperparathyroidism Due to Chronic Kidney Disease. Tominaga, Yoshihiro; Tsuzuki, Toyonori; Matsuoka, Susumu; Uno, Nobuaki; Sato, Tetsuhiko; Shimabukuro, Syuichi; Goto, Norihiko; Nagasaka, Takaharu; Uchida, Kazuharu // World Journal of Surgery;May2008, Vol. 32 Issue 5, p815 

    Recently, somatic inactivating mutations in HRPT2 have been reported in the majority of sporadic parathyroid carcinoma in primary hyperparathyroidism (HPT). Parafibromin is a tumor suppressor protein encoded by HRPT2, and loss of nuclear expression of parafibromin was found in approximately 70%...

  • Something to shoot for. Cox, Bart // Joe Weider's Muscle & Fitness;Sep98, Vol. 59 Issue 9, p24 

    Recounts the experience on how a bodybuilder overcame a tumor in the parathyroid gland. Symptoms of the tumor; Resolution made while in the hospital bed; Recuperation from the disease.

  • CONCOMITANT HYPERPARATHYROIDISM AS A CAUSE OF THE HYPERCALCEMIA ASSOCIATED WITH HYPERTHYROIDISM. Jackson, Charles E.; Webster, Joel S.; Talbert, Pierre C.; Caylor, Harold D. // Annals of Internal Medicine;May61, Vol. 54 Issue 5, p992 

    Describes the case of a patient in whom the hypercalcemia associated with hyperthyroidism was caused by a concomitantly hyperfunctioning parathyroid adenoma. Case history; Diagnosis; Effect of propylthiouracil on the serum calcium level in hyperparathyroidism.

  • Hypercalcemic crisis in a young woman. Steenkamp, Devin; Lee, Stephanie L. // Endocrine Today;Oct2011, Vol. 9 Issue 10, p17 

    The article describes the case of hypercalcemia in a 21-year-old woman diagnosed of primary hyperparathyroidism (PHP) caused by benign parathyroid hormone (PTH) adenoma.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics